Advertisement


Laurie H. Sehn, MD, MPH, on Follicular Lymphoma: Choosing the Best Target

2016 ASH Annual Meeting & Exposition
Tweet this page

Laurie H. Sehn, MD, MPH, of the British Columbia Cancer Agency, discusses agents in the pipeline for follicular lymphoma, including drugs targeting the immune microenvironment, novel monoclonal antibodies, and emerging immunotherapeutics.

Advertisement

Advertisement



Advertisement

click me